Concepedia

Eugen Lounkine

EL

Statistics

Publications

25

Citations

2.3K

H-Index

17

Active since

2008

Affiliations

Novartis (Switzerland)(Current)

University of Bonn

Novartis Institutes for BioMedical Research

Novartis (United States)

University of California, San Francisco

Eugen Lounkine is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2008–2019

25

Publications

25

Large-scale prediction and testing of drug activity on side-effect targets

Eugen Lounkine, Michael J. Keiser, Steven Whitebread et al. · Nature · 2012 · 897 citations · Full text

, , +16

Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers

Julien P. N. Papillon, Katsumasa Nakajima, Christopher D. Adair et al. · Journal of Medicinal Chemistry · 2018 · 237 citations · Full text

, , +11

Identifying mechanism-of-action targets for drugs and probes

Elisabet Gregori‐Puigjané, Vincent Setola, Jérôme Hert et al. · Proceedings of the National Academy of Sciences · 2012 · 181 citations · Full text

, , +17

Rethinking Molecular Similarity: Comparing Compounds on the Basis of Biological Activity

Paula Petrone, B. T. Simms, Florian Nigsch et al. · ACS Chemical Biology · 2012 · 162 citations

, , +17

Dark chemical matter as a promising starting point for drug lead discovery

Anne Mai Wassermann, Eugen Lounkine, Dominic Hoepfner et al. · Nature Chemical Biology · 2015 · 134 citations

, , +14

1–5 of 25